| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |










From the University of Malaya,* Kuala Lumpur, Malaysia; the Ministry of Health,
Kuala Lumpur, Malaysia; and the Centers for Disease Control and Prevention,
Atlanta, Georgia
| Abstract |
|---|
|
|
|---|
160 miles south in the state of Negri Sembilan.1
Later, the infection spread to workers in an abattoir in Singapore, where pigs originating from Negri Sembilan were held and slaughtered.3,4
There were 105 deaths among 265 reported cases of encephalitis, a mortality rate of nearly 40%.5
Most patients presented with a severe acute encephalitic syndrome, but some also had significant pulmonary manifestations.3,6,7
A syncytium-forming virus was isolated from the cerebrospinal fluid (CSF) of several patients. Electron microscopy (EM) examination revealed an enveloped virus with filamentous nucleocapsids, which when negatively stained showed a herringbone structure, characteristic of the family Paramyxoviridae.8
Reactivity of infected culture cells and tissues from fatal cases with anti-Hendra antibodies by immunofluorescence and immunohistochemistry (IHC) as well as detection of anti-Hendra IgM antibodies in the serum and CSF suggested the possibility of Hendra or Hendra-like virus infection.1
Preliminary autopsy findings showed that the central nervous system (CNS) seemed to be a major target.2,3,8
Viral genomic sequencing provided evidence that this previously unknown virus is related to, but distinct from, Hendra virus.8,9
The virus was subsequently named Nipah virus after Kampung Sungai Nipah (Nipah River Village), where the first viral isolates were obtained.7,10 This study is based on the clinical and autopsy findings for 32 patients who died of Nipah virus infection. We examined the relative usefulness of various laboratory tests, including IHC, serology, and virus isolation, for the diagnosis of this emerging infectious disease. We also describe the pathological findings, including EM and tissue immunolocalization of viral antigens, and discuss the pathogenesis of Nipah virus infection based on these findings.
| Materials and Methods |
|---|
|
|
|---|
A series of 32 fatal cases of Nipah infection, which comprised all of the cases autopsied from late 1998 to mid-1999, was drawn from five hospitals in Malaysia. Fifteen cases were from the Seremban hospital (Table 1
, cases 1 to 15); three from the Kuala Lumpur hospital (cases 16 to 18); nine from the Ipoh hospital (cases 19 to 27); four from the University of Malaya Medical Center, Kuala Lumpur (cases 28 to 31); and one from the Kelang hospital (case 32). Medical records from the various hospitals were systematically reviewed, and demographic, clinical, and other data were extracted.
|
Of the 32 autopsies, 29 were full autopsies and 3 were limited to the brain. Tissues were fixed in 10% buffered formalin, paraffin-embedded, and stained with hematoxylin and eosin (H&E).
Antibodies, Cell and Tissue Controls
The antibody initially used for Nipah viral antigen detection was anti-Hendra hyperimmune mouse ascitic fluid [Centers for Disease Control and Prevention (CDC), Atlanta, GA]. Subsequently, hyperimmune mouse ascitic fluid against Nipah virus was generated at the CDC and reactivity was compared with that of the mouse anti-Hendra antibody. The specificity and sensitivity of these antibodies in the IHC analyses were tested by using Vero E6 cells (Vero clone CRL 1586; American Type Culture Collection, Rockville, MD) that were uninfected or infected with Hendra or Nipah virus. Antibody specificities were further confirmed by testing specimens from patients with Japanese encephalitis (JE), measles, eastern equine encephalitis, enterovirus71, or influenza, and tissue culture cells infected with western equine encephalitis virus, measles virus, or La Crosse encephalitis viruses.
Negative antibody controls for each slide in the IHC analysis included replacing primary antibody with normal mouse ascitic fluid or with the primary antibody absorbed with Nipah virus antigens. Because there was a high initial suspicion of JE, specimens from all patients were also stained for JE viral antigens by using a cross-reactive anti-flavivirus antibody.
IHC
Tissue blocks were chosen for IHC analysis after slides of the H&E-stained specimens were reviewed. The IHC was based on a method described previously for hantavirus.11 Briefly, 4-µm sections were deparaffinized and rehydrated through graded alcohol and distilled water. They were predigested by 0.1 mg/ml of proteinase K (Boehringer-Mannheim Corp., Indianapolis, IN) in 0.6 mol/L of Tris (pH 7.5)/0.1 CaCl2 for 15 minutes at room temperature and blocked with normal swine serum. Primary antibodies were applied for 1 hour at room temperature. Optimal conditions for primary antibody and digestion conditions were previously determined by titration experiments. For anti-Hendra and anti-Nipah antibodies, the dilutions were 1:4000 and 1:2000, respectively. This step was followed by sequential application of biotinylated link antibody, alkaline phosphatase-conjugated streptavidin, and napthol fast red according to the manufacturers protocol (LSAB2 Universal Alkaline Phosphatase Kit; DAKO Corporation, Carpinteria, CA). Sections were then counterstained in Meyers hematoxylin (Fisher Scientific, Pittsburgh, PA) and mounted with an aqueous mounting medium (Faramount; DAKO Corporation). Specimens from all cases were tested with anti-Hendra antibody and selected cases with anti-Nipah antibody.
EM
Formalin-fixed brain tissues were postfixed with 1% osmium tetroxide in 0.1 mol/L of phosphate buffer, en bloc stained with 4% aqueous uranyl acetate, dehydrated through a graded series of alcohols and propylene oxide, and embedded in a mixture of epon substitute and Araldite.12 Ultrathin sections were stained with 4% uranyl acetate and Reynolds lead citrate.
Nipah Antibody Detection Assays
IgM and IgG antibodies to Nipah virus in patients were detected by enzyme-linked immunosorbent assay using cross-reactive inactivated Hendra virus antigens. Both tests followed methods previously described for Ebola virus.13
In brief, the IgM assay was performed in a Mu-capture format and used Hendra antigens obtained from virus-infected
-irradiated Vero E6 cells and anti-Hendra hyperimmune mouse ascitic fluid antibody. The IgG assay used a detergent-extracted Hendra antigen obtained from infected Vero E6 cells and inactivated by
irradiation; antigen was adsorbed directly onto microtiter plates. Control IgG and IgM assays were also performed with antigens from mock-infected Vero E6 cells. The IgM-capture assay used goat anti-human Mu to capture IgM (Biosource, Camarilla, CA) and a horseradish peroxidase-conjugated goat anti-mouse IgG (Biosource). The IgG assay used a horseradish peroxidase-conjugated mouse anti-human
-chain-specific antibody (Accurate Chemical, Westbury, NY) to detect bound IgG.
Sera were tested in a fourfold dilution series from 1:100 to 1:6400, and CSF was similarly tested in a fourfold series from 1:20 to 1:1280. A sample of negative donors was used to validate the cutoff values for the assays. Samples were considered positive for the IgM assay if the sum of the adjusted optical densities from all of the dilutions (infected antigen less the mock-infected antigen) was >0.45 through the entire dilution series and the titer was
1:400 (1:16 for CSF). Samples were likewise considered positive in the IgG assay if the sum for the adjusted optical densities from all of the dilutions (infected antigen less the mock-infected antigen) was >0.90 through the entire dilution series and the titer was
1:400 (
1:80 for CSF).
Virus Isolation and Identification
Virus isolation and identification were attempted with specimens from eight patients by use of a previously described method.14 In brief, 100 µl of CSF was innoculated on previously seeded wells with 105 Vero cells (CCL-81; American Type Culture Collection); and the cells were transferred to 1 ml of Eagles minimal essential growth medium containing 10% fetal calf serum (Flowlab, Sydney, Australia). After incubation at 37°C, positive identification of virus was made by immunofluorescence using anti-Hendra hyperimmune mouse ascitic fluid and goat anti-mouse IgG fluorescein-isothiocyanate conjugate (Sigma, St. Louis, MO) secondary antibody.
| Results |
|---|
|
|
|---|
The age of patients in this study ranged from 13 to 75 years (mean, 43 years; median, 44 years) and the male-to-female ratio was 29:3. The prodrome, defined as the time from fever onset to the day of hospital admission, averaged 3.3 days (range, 1 to 7 days) (Table 1)
. The duration of illness, defined as the time from fever onset to death, averaged 9.5 days (range, 2 to 34 days). Four patients survived >14 days before death. Case 32 had a similar clinical illness a few months earlier, improved, but subsequently relapsed and died.
Clinical symptoms and signs are summarized in Table 2
. All patients had fever. More than 70% of patients complained of drowsiness, headache, and disorientation or confusion. The most frequent clinical sign among patients was reduced consciousness. Case 31 was recovering in the hospital ward when he developed massive fatal intracerebral hemorrhage.
|
The macroscopic features were nonspecific. In the CNS, lesions were generally difficult to identify; however, in a few cases, small, discrete, occasionally hemorrhagic, necrotic lesions were found. Only 2 of 10 brains examined showed unequivocal herniation. Case 29 had cerebellar tonsil herniation, and case 31 had uncal herniation and showed a large intracerebral clot in the frontal lobe with intraventricular extension and Duret hemorrhages in the midbrain and pons. Histopathological changes were seen in the blood vessels and parenchyma of multiple organs and are presented accordingly.
Blood Vessels
The distribution of histopathological lesions and immunostaining is shown in Table 3
. Extensive involvement of blood vessels in the CNS, lung, heart, and kidney was observed in Nipah virus infection. However, blood vessels in the CNS were the most severely involved. Typically, small arteries, arterioles, capillaries, and venules showed evidence of vasculitis. Vasculitis was not found in medium-sized vessels (eg, renal artery and vein, anterior, and middle cerebral arteries) or large arteries (eg, aorta and pulmonary trunk). No vasculitis was found in the relapse encephalitis case (case 32; Table 1
).
|
|
|
|
In the CNS, the main pathological findings were vasculitis, thrombosis, parenchymal necrosis, and presence of viral inclusions (Table 4
and Figures 1, 3, 4, and 5
). Vascular involvement of gray and white matter was seen throughout the CNS. The spinal cord was examined in eight cases and showed similar pathological lesions in three cases as observed elsewhere in CNS. Pathological lesions similar to those seen elsewhere in CNS were seen in spinal cords of three of eight cases examined. The olfactory bulb was examined in nine cases and did not show any significant histopathology. Common histopathological lesions and their relative frequency in the CNS are summarized in Table 4
.
|
|
0.2 mm to
5 mm. Vasculitis, thrombosis, and various degrees of parenchymal edema and inflammation were frequently found in the vicinity of these plaques (Figure 4, A and B)
Viral inclusions were found in the cytoplasm and nuclei of neurons, although the latter were generally harder to find. Most inclusions were found near vasculitic vessels or necrotic plaques. Cytoplasmic inclusions were usually small, discrete, eosinophilic, and sometimes multiple (Figure 3A)
. Nuclear inclusions were less commonly found and occupied most of the nucleus except for a thin rim of chromatin at the periphery (Figure 3C)
. Although inclusions were found in 63% of cases (Table 4)
, in many instances they were found in only a few neurons after an extensive search.
The CNS pathology in the relapse encephalitis case (case 32; Table 1
) was somewhat different from other cases (Figure 5)
. Viral inclusions were much more extensive and prominent, occupying either the entire neuronal cytoplasm or having a more peripheral distribution; inclusions were also abundant in the neuropil. The parenchymal lesions were larger and more confluent, occasionally hemorrhagic, and associated with severe neuronal loss, gliosis, and abundant macrophages. No vasculitis or typical necrotic plaques were seen and perivascular cuffing was not a prominent feature.
|
In the lung, vasculitis was seen in 62% of cases (Table 3
; Figure 1, A and B
) and fibrinoid necrosis was found in 59% of cases. Fibrinoid necrosis often involved several adjacent alveoli and was frequently associated with small vessel vasculitis (Table 3
, Figure 6A
). Multinucleated giant cells with intranuclear inclusions were occasionally noted in alveolar spaces adjacent to necrotic areas (Figure 6; B, C, and D)
. Alveolar hemorrhage, pulmonary edema, and aspiration pneumonia were often encountered. Histopathological changes of bronchiolar epithelium were uncommon except in one case in which a large bronchus showed severe transmural inflammation and ulceration (case 22; Table 1
).
|
|
|
EM examination of CNS specimens showed inclusions typical of viruses of the family Paramyxoviridae consisting of smooth, filamentous nucleocapsids associated with dense amorphous material (Figure 9, A and B)
. These inclusions were generally difficult to locate by ultrastructural examination and were mostly seen in neuronal bodies and dendritic processes (Figure 9, A and B)
and occasionally within endothelial cells (Figure 9, C and D)
. In addition, unusual cytoplasmic inclusions composed of aggregates of smooth curvilinear membranes were found in neurons (Figure 9E)
. No mature viral particles were found in specimens examined.
|
Antibody Apecificity
Anti-Hendra and anti-Nipah antibodies showed similar specificity reacting with viral antigens in formalin-fixed infected Vero E6 cells. After absorption with excess viral antigen, these antibodies failed to react with infected cells. No staining was seen when uninfected cell controls were reacted with either antibody. Tissues from other types of viral encephalitides were negative when tested with anti-Hendra and anti-Nipah antibodies, and all Nipah cases were negative when tested with anti-flavivirus antibody.
Cellular Targets and Distribution of Nipah Viral Antigen
Blood Vessels: Immunostaining of Nipah viral antigens was seen in blood vessels of most organs, particularly in those with vasculitis. No vascular staining was found in spleen or liver. Vascular staining was seen mainly in endothelium, endothelial syncytia (Figure 1, F and G
, and Figure 8, B and F
), and smooth muscle of the tunica media (Figure 6, E and F)
. No staining was present in medium-size or larger arteries.
CNS: In the CNS, apart from blood vessels, the most prominent staining was seen in neurons associated with necrotic plaques or vasculitis. However, not all plaques were associated with viral antigen staining. Neuronal staining at the periphery of necrotic plaques was usually in the form of either concentric or eccentric rings (Figure 4C)
. The occasional remaining neurons in plaques and microcystic areas showed positive staining (Figure 4F)
. Occasionally, areas of neuronal staining with no demonstrable adjacent plaque or vasculitis were seen. Cytoplasmic and nuclear staining were observed as granular or homogeneous in the neurons and peripheral processes of the perikaryon (Figure 3, B and D
; and Figure 4, D, E, and F
). Immunostained round or oval granules (Figure 3B)
corresponded to cytoplasmic viral inclusions as seen with H&E (Figure 3A)
. Immunostaining was seen in three of eight of the spinal cords examined and was localized in areas with parenchymal necrosis, inflammation, and syncytial cell formation.
Immunostaining of glial cells (astrocytes or oligodendrocytes) was seen in rare cells (Figure 4H)
. This relative sparing of glial cells was clearly evident in the putamen, where pencil bundles of Wilson (white matter tracts) immediately adjacent to positively stained neurons showed no immunostaining (Figure 4G)
. Similarly, there was general sparing of the white matter tracts in the anterior pons in contrast to abundant pontine nuclear staining. Focal immunostaining of the ependyma (Figure 5D)
was seen in several cases; the choroid plexus was negative for viral antigen in all cases.
In the case of relapse encephalitis (case 32; Table 1
), glial and neuronal staining was more diffuse and prominent compared with that for the other cases (Figure 5; B, C, and D)
. In contrast to findings for the acute cases, the blood vessels of case 32 were negative for Nipah viral antigens.
Non-CNS Organs: Localization of viral antigen was clearly seen in the non-CNS tissues, although to a lesser extent (Table 3)
. Twenty-four percent of cases were positive by IHC in the lung and kidney, compared with 84% in the CNS. In the lung, viral antigens were usually found in areas of fibrinoid necrosis and in blood vessels (Figure 6; B, E, and F)
. Viral antigens were also noted in multinucleated giant cells in or lining the alveolar space in three cases (Figure 6D)
. Only one case had bronchial inflammation and unequivocal staining of the bronchiolar epithelium (case 22; Table 1
and Figure 6, G and H
).
In the kidney, glomerular capillaries, small blood vessels, and syncytial cells in the periphery of the glomerulus exhibited viral antigen staining (Figure 8B)
. In the heart, IHC staining was found mainly in the blood vessels (Figure 8F)
. In one case, there was focal staining of cardiac myocytes (Figure 8G)
. Nipah virus antigen was identified in macrophages and multinucleated giant cells in the spleen and lymph nodes (Figure 7C)
. No immunostaining of viral antigens was seen in the liver. In the relapse case, immunostaining was not seen outside of the CNS.
Nipah Antibody Detection Serological Assays
Nipah IgM antibodies were more often detected than IgG in serum and CSF of patients (Table 1)
. In the single largest group of 18 patients with duration of illness of 6 to 10 days, IgM was found in the serum of 94% and the CSF of 64%, and IgG was found in 12% and 9%, respectively. IgM antibodies generally appeared earlier than IgG and in the serum before CSF (Figure 10)
.
|
All cases in this study were examined by IHC, and serology was performed on serum or CSF of all but one case. IHC analysis showed 87% of cases to be positive for viral antigen, and 94% of cases had positive Nipah antibody results in the serum and/or CSF (Table 5)
. There was an 81% correlation between positive IHC and serology. Discrepancies between IHC and serological assays were found in six cases; four of these cases were IHC-negative and serology-positive, and two cases were IHC-positive and serology-negative. Another IHC (case 15) had no serology available (Table 5)
.
|
Virus isolation from the CSF was attempted for eight cases and successful for all but one, which was also IHC-negative (case 31; Table 1
).
Temporal Evolution of Lesions and Presence of Viral Antigens in the CNS
The temporal evolution of histopathological lesions and viral antigens in the brain in acute fatal Nipah infection is shown in Figure 2
. Vasculitis, thrombosis, necrotic plaques, and syncytia peaked between 6 and 10 days after fever onset. On the other hand, parenchymal inflammation and perivascular cuffing were most severe 11 to 15 days after fever onset and were found in >60% of tissue sections of cases with duration of illness >16 days.
Viral antigens were more commonly detected in tissues 6 to 10 days after fever onset and gradually decreased throughout time. Tissues of all 18 patients with a 6 to 10 day duration were positive by IHC. In contrast, among the four patients whose duration of illness was >16 days, only one (case 26) was IHC-positive (Table 1)
.
| Discussion |
|---|
|
|
|---|
The diagnosis of Nipah virus infection, suspected by history and clinical manifestations, can be supported by characteristic histopathological findings. These histopathological findings include syncytial giant cell formation, vasculitis, and viral inclusions. Other CNS changes observed, including perivascular cuffing, parenchymal inflammation, and neuronophagia, are rather nonspecific features and can be found in other acute viral encephalitides.29-31 From a diagnostic standpoint, perhaps the most unique histopathological finding is the presence of syncytial multinucleated endothelial cells. To our knowledge, this feature has not been described in other infective encephalitides other than Hendra virus encephalitis.32 However, this feature occurred in only approximately one-fourth of the cases and cannot be used as a sensitive criterion for the diagnosis of Nipah virus infection. There is a higher likelihood of identifying these cells in small blood vessels of the CNS of patients who succumb early to the disease. The presence of multinucleated giant cells of nonendothelial origin found in the kidney at the edge of the glomerulus also seems to be a unique, albeit relatively rare, feature of Nipah virus infection. Characteristic multinucleated giant cells were also seen in the lung, spleen, and lymph nodes; however, these cells can also be seen in measles virus, respiratory syncytial virus, parainfluenza virus, herpesvirus, and other infections and therefore are not unique to Nipah virus infection.33-37
Widespread vasculitis with predominant CNS involvement is a useful histopathological feature that may suggest the diagnosis of Nipah virus infection. Many infectious agents can cause vasculitis, including herpesviruses, rickettsiae, and Neisseria.38 However, the histopathological features are somewhat different in these infections. In rickettsial encephalitis,39 vasculitis is usually more subtle and CNS necrosis less prominent than seen in Nipah virus encephalitis. Varicella-zoster and herpes simplex infections may be associated with granulomatous angiitis, a feature not seen in Nipah virus infection.40,41
Finally, the diagnosis of Nipah virus infection can be supported by the histopathological and ultrastructural appearance and distribution of characteristic viral inclusions. However, similar inclusions can be seen in other paromyxoviral infections,33,42 and therefore unequivocal diagnosis can be made only by laboratory tests such as IHC, virus isolation, PCR, and serology.
The utility of IHC as a diagnostic modality was established by correlation with results of virus isolation and serological assays. Virus can be isolated from the CSF, respiratory secretions, and urine of patients14
but should be done in biosafety level 4 laboratory facilities. The combination of IHC and serological tests established the diagnosis for all cases regardless of duration of illness. Four seropositive and IHC-negative cases had duration of illness of
14 days, emphasizing the important role of serology in the diagnosis and suggesting that in most cases viral antigens are cleared by 2 weeks after infection. Conversely, the three IHC-positive cases with negative or unavailable serological results underscore the importance of IHC in the diagnosis of fatal Nipah virus infection. CNS is the optimal tissue for IHC analysis because it was three to four times more likely to be positive for Nipah virus antigens than were lung or kidney tissues, the next most likely organs to be positive (Table 3)
.
In this study, several lines of evidence allowed for precise characterization of viral tropism and its consequences. Epithelial cell involvement, although not common, included bronchiolar mucosa, renal tubules, and podocytes at the edge of the glomerulus. Endothelial cells and neurons had a remarkably high viral load, as evidenced by immunostaining of Nipah virus antigens. The ultrastructural finding of inclusions in endothelial and neuronal cells is consistent with replication in these sites.43,44 In situ hybridization studies also confirm involvement of these cells in viral replication (data not shown). There is considerable diversity and heterogeneity of endothelial cells. Our data showed that small vessels, such as small arteries, arterioles, venules, and capillaries, were more prone to vasculitis and thrombosis than were larger vessels. Differences in endothelial susceptibility to viral infection could certainly account for the different frequencies of vasculitis in various organs: CNS, 80% of cases, followed by the lung, heart, and kidney with 62%, 31%, and 24%, respectively.
Widespread vasculitis, a key event in the pathogenesis of Nipah virus infection, seems to be a consequence of infection of the vascular endothelial and smooth muscle cells. Overall, the frequency of vasculitis seemed to be proportional to necrosis and necrotic plaques, particularly in the CNS and lung. The necrotic plaques and the acute encephalitic syndrome may stem from both direct neuronal infection and ischemic injury (Figure 11)
. This sequence of pathological events is supported by the concomitant increase in frequency of syncytia, vasculitis, thrombosis, necrotic plaques, and viral antigen in the CNS (Figure 2)
.
|
The appearance of similar pathological lesions in several organs at the same time suggest an early viremic phase that follows primary viral replication. In measles, another paramyxoviral infection, primary viral replication occurs in respiratory tract mucosa and lymphoid organs and is followed by a cell-associated viremia.46
In this series of fatal Nipah virus cases, the extensive lymphoid necrosis and immunostaining of lymphoid and respiratory tissues suggest that these tissues can also be similarly involved in primary replication. Endothelium, although unlikely to be a primary replication site, may act as a site of secondary viral replication and amplification of viremia. The temporal sequence of antibody rise first in serum and then in the CSF provides indirect evidence that viremia occurs before CNS infection and probably reflects the fact that induction of antigen-specific, antibody-secreting B cells first occurs in the peripheral lymphoid tissues (Figure 10)
.
CNS predilection, as evidenced by pathological changes and viral immunolocalization, correlates well with the encephalitic syndrome reported in fatal and nonfatal cases.2,3,6
In this series of fatal cases, predominant clinical features included drowsiness, disorientation, confusion, segmental myoclonus, and areflexia. Clinically, nonfatal cases also undergo a similar, less-severe acute encephalitic syndrome.6
Brain magnetic resonance imaging studies of nonfatal and fatal cases show similar scattered, small, and discrete lesions that probably represent necrotic plaques.47-50
In our study, CNS pathological changes were more severe than histopathological changes in other organs. This finding also correlates with the lower frequency of non-CNS clinical manifestations (Table 2)
. A pulmonary syndrome was reported in some cases from Singapore,3
and 40% of cases described in this study had cough or respiratory symptoms. These symptoms could be related to pulmonary lesions, such as necrosis, edema, and hemorrhage.
The sequelae of acute Nipah virus infection are still unclear. Acute encephalitis probably occurs in a significant proportion of cases after exposure to virus. Mortality from acute Nipah encephalitis may be as high as 30 to 40% and is more likely in patients with brainstem signs and virus isolated from CSF.6,51
Approximately 15% of patients with acute encephalitic syndrome develop residual neurological deficits.6
Asymptomatic cases have also been reported with rare late-onset encephalitis
10 weeks after exposure.6,50,52
Overall, the prevalence of relapse Nipah encephalitis and late-onset encephalitis in initially asymptomatic patients is estimated to be
7.5% and 3.4%, respectively (CT Tan, personal communication). Case 32 is likely a relapse case because of the clinical course and pathological findings of excessive CNS viral inclusions and confluent necrotic plaques. This diagnosis is also supported by results showing elevated IgG, but not IgM, and the histopathological absence of vasculitis. The clinical, radiological, and pathological features of this case are similar to those of a patient with Hendra virus infection who initially had aseptic meningitis and recovered, only to suffer a fatal meningoencephalitis 13 months later.6,32,50
This clinical spectrum is also somewhat similar to that of other paramyxoviruses, such as measles virus, that can cause both acute and subacute progressive encephalitides.46
The emergence of novel paramyxoviruses, such as Hendra and Nipah, throughout a short span underscores the importance of these viruses as zoonotic agents.53,54 Human Nipah virus infection most likely originated from direct contact with pigs that also acted as intermediate and amplifying hosts rather than as natural hosts.5,8,55,56 Studies indicate that virus transmission from pig to humans resulted from direct contact with these animals and that the risk of person-to-person transmission is extremely low.5,14,57,58 Although the natural host for Nipah virus appears to be the fruit bat from the Pteropus family,59 the mode of virus transmission to pigs is still under investigation.
A fundamental principle in the concept of emerging infectious diseases is recognition of disease. As illustrated in this report, recognition and description of a disease by pathologists as part of a multidisciplinary team plays a key role in furthering the understanding of emerging infectious diseases. This investigation also highlights the important role of autopsies in combination with contemporary pathological methods in providing insights into the pathogenesis of new clinical entities.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by the Ministry of Health, Malaysia, the University of Malaya Medical Center, and the Malaysian Government (research grant 06-02-03-0743.
The Nipah Virus Pathology Working Group at CDC, Atlanta, consists of Jeanine Bartlett, Tara Ferebee-Harris, Patricia Greer, Lisa M. Harper, Jeltley Montague, Tim Morken, and Chalanda Smith; and in Malaysia, Sharifah Safoorah Syed Alwee, Thuaibah Hashim, Khairul Azman Ibrahim, Fauziah Kassim, Lily Manoramah, George Paul, Norraha Abdul Rahman, Kalyani Supramaniam, Thayaparan Tarmizi, Nor Yatizah Mohd Yatim, Rosna Yunus, and Suryati Yusuf.
Accepted for publication August 26, 2002.
| References |
|---|
|
|
|---|
Related articles in Am J Pathol:
This article has been cited by other articles:
![]() |